Participants' daily steps decreased from about 5,047 to 4,487 per day. Moderate-to-vigorous physical activity also dropped, from 28 minutes a day to 22 minutes a day,
New research suggests that people with obesity who take GLP-1 drugs appear to scale back on physical activity once they start taking the drug.
A study presented on June 14 at ENDO 2026, the Endocrin… [+3479 chars]
Discussion (0)
No comments yet. Be the first to share your thoughts!
Join the Conversation
You need to be logged in to leave a comment.
Sign In Create Account